https://www.selleckchem.com/pr....oducts/hexamethonium
scores were significantly associated with 12-month changes in EQ-5D-3L index scores in both groups (β = - 0.73, 0.001 and β = - 0.40, = 0.003, respectively). Patients with RA in persistent MDAS experience substantial ongoing physical disability, poor QoL, and pain. HAQ-DI is an important predictor of future disability and reduced QoL, supporting current national recommendations to measure HAQ-DI in routine care. Patients with RA in persistent MDAS experience substantial ongoing physical disability, poor QoL, and pai
Like
Comment
Share
